News Focus

The Scientific Challenge of Hepatitis C

See allHide authors and affiliations

Science  02 Jul 1999:
Vol. 285, Issue 5424, pp. 26-30
DOI: 10.1126/science.285.5424.26

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

The hepatitis C virus (HCV) infects some 170 million people worldwide--more than four times as many as HIV--and is causing rising rates of liver disease. Like HIV, it is a wily foe for researchers developing drugs and vaccines, because HCV also mutates rapidly, creating a swarm of different viruses in each infected person that can thwart antibodies easily. But progress is beginning to be made: Although to date no one has been able to grow HCV reliably in a laboratory culture of cells, on page 110, researchers describe a new system for culturing HCV's RNA. And a study on page 107 offers one possible explanation for why some HCV strains are more resistant to interferon, the standard treatment for HCV, than others.

    View Full Text

    Stay Connected to Science